Newly Added Classes


HRS Learning Center with activities
There are over 50 various activities available with and without credit.


ExP Learning ExPerience™
The EP Learning ExPerience™ will expand upon clinical EP and technical concepts, leading to critical thinking skills for understanding the complexities of clinical EP through a truly unique educational and social forum — all delivering precisely what you need to become a confident EP professional. Target Audience: Allied Professionals, Advanced Practice Providers, EP Fellows and/or Industry Professionals working in the EP Field. What’s Included: 50+ Interactive learning modules with interactive images, paired with comprehensive study guides 70+ CEUs offered for Nurses and Techs (ARRT Category A+) 400+ Knowledge Check Questions with results feedback Access to learn and share with a network of EP professionals 12 month access, with option to re-subscribe for $297/year Estimated Completion Time: 75 – 80 Hours


Virtual Event: Cryoballoon PVI for the Treatment of Persistent Atrial Fibrillation
This program is designed to discuss the clinical evidence supporting PVI for persistent AF and STOP Persistent AF trial results.


ISHNE ECG UNIVERSITY
Basic ECG Diagnosis Course.


Virtual Event: Cryoballoon PVI for the Treatment of Persistent Atrial Fibrillation
This program is designed to discuss the clinical evidence supporting PVI for persistent AF and STOP Persistent AF trial results.


Real-Time Dynamic Mapping: Optimizing workflow procedures and outcomes
This dynamic, interactive, and highly educational webinar focused on exciting and innovative mapping solutions has been designed to enhance the learning experience and professional growth for physicians, fellows and staff of all levels. Dr. Li-Wei Lo will review outcomes data on the use of new dynamic mapping and visualization tools to enable rapid identification of ablation targets and gaps in the ablation line, improve outcomes through real-time assessments of electrograms, and decrease mapping time and prevention of relevant data loss due to delayed point acquisition. Dr. Rajesh Venkataraman will share his clinical experiences with the EnSite™ LiveView Dynamic Display with Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ for improved procedural efficiency and outcomes in PVI through an illustrative case review.


Virtual Event: Best Practices in Short- to Long-term Cardiac Monitor Conversion through COVID-19 and Beyond
Join us for a discussion with Dr. Avneet Singh as he shares his approach to cardiac monitoring during COVID-19 and beyond. Learn how to effectively select the ideal cardiac monitor for each patient. For patients in which cardiac monitoring is initiated using a monitor for less than 30 days, learn best practices for transitioning such patients to a long-term monitor should the initial monitor be inconclusive. Dr. Singh will share his extensive learnings and practices, including his In-Office approach to long-term monitoring during COVID-19.


Virtual Event: Perspectives on Same-Day Discharge
This program is designed to discuss concepts and practices that may improve procedural efficiencies during cryoballoon ablation procedures.


Virtual Event: ASQ with the Experts
Join our expert panel as they discuss their experiences with the Attain Stability™ Quad active fixation left ventricular (LV) lead, including a review of case studies, perspectives on extraction, and how patients have benefited from this latest advancement in LV lead technology.


The Josephson and Wellens “How to Approach Complex Arrhythmias”
The Josephson and Wellens Digital Experience delivers groundbreaking expert instruction on the interpretation of complex arrhythmias. This Medtronic Academy program preserves the legendary teachings of Mark Josephson, M.D., and Hein Wellens, M.D., and is designed for healthcare professionals with an understanding of advanced electrocardiography who wish to further their knowledge of complex ECG arrhythmia interpretation.


Appropriate Stroke Prevention Strategies in AF: One Size Does Not Fit All
The goal of this activity is to review the use of non-vitamin K antagonist oral anticoagulants (NOACs) to prevent atrial-fibrillation-related stroke in various patient populations.


Management of Atrial Fibrillation, Stroke and Bleeding: Evidence From Clinical Practice
Screening for Atrial Fibrillation to Prevent Strokes — Where Are We Now?, NOAC-Related Intracranial Hemorrhage — Risk, Clinical Presentation, and Predictors, Oral Anticoagulants: What Did We Learn in Clinical Practice?, and NOACs: Can the Effect Be Reversed in Acute Situations?


Managing Embolic Risk in AF Patients With Renal Impairment: Case Considerations
Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices—order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface. Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case.


Anticoagulants in Interventional Cardiology: Where Are We in 2018?
All sections of this activity are required for credit. An Overview of Anticoagulation in Interventional Cardiology, The Use of NOACs in the Setting of AF and PCI, Exploring the Use of NOACs in the Setting of TAVR and Transitioning Care From Post-Procedure to Long-Term Management.


Identifying High-Risk AF Patients: Are Biomarkers the Answer?
The goal of this activity is to increase knowledge in risk stratification and identification of patients who should receive anticoagulation and to gain competence in instituting appropriate antithrombotic therapy in patients at risk for stroke based on clinical trial data.


Oral Anticoagulation in AF: From Evidenced-Based Medicine to Daily Clinical Practice
Anticoagulation is a very safe option in patients with AF. The NACS allows physicians to treat elderly, frail patients in whom there is often concern about the safety of anticoagulation. Real-world data is helpful to understand our practice patterns and to objectivize our fears as healthcare professionals, but they are less useful for comparative effectiveness.


The Clinical Effect of Cryoenergy for Pulmonary Vein Isolation: Insights on the Science and Outcomes
Watch as Dr. Robert Kowal, Dr. Hugh Calkins, and Dr. Wilber Su discuss the unique science and clinical outcomes behind cryoablation therapy while performing a pulmonary vein isolation (PVI) ablation with an Arctic Front Advance™ Cardiac Cryoablation Catheter in a patient with drug-refractory, recurrent, symptomatic paroxysmal atrial fibrillation.


Heart Rhythm Interpretation – Basic ECGs
Correlating the normal cardiac conduction pathway to the mechanical function of the heart and to an ECG tracing. Normal range of a P-R interval and the width of a QRS complex in a normal sinus beat. Key characteristics of normal sinus rhythm in terms of rate, regularity, and rhythm. Typical rate ranges for basic arrhythmias. Analysis of a given ECG rhythm by describing the relationship between the P wave and QRS complex and determining regularity/irregularity.


High-Density Mapping in Atrial Fibrillation: The Mount Sinai’s Experience
Electrophysiologists at Mount Sinai Medical Center in New York City will share their knowledge of optimal mapping and ablation strategies for managing Atrial Fibrillation. A comprehensive review of clinical decision making strategies will assess the latest technology to manage arrhythmias through a live case as well as a question and answer session.


Catheter Ablation of VT in Normal Hearts
Reviewing key points on catheter ablation of ventricular tachycardia (VT) in structurally normal hearts


Catheter Ablation of VT in Structural Heart Disease
Reviewing key points on catheter ablation of ventricular tachycardia (VT) in structural heart disease


2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation
May 12, 2017 The 2017 Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation represents a complete rewrite of the 2012 HRS/EHRA/ECAS Expert Consensus Statement. This document provides updated definitions, mechanisms, and rationale for atrial fibrillation (AF) ablation and consensus recommendations concerning indications, strategies, techniques, and endpoints, technology and tools, and follow-up considerations for AF ablation.


ADVICE: Adenosine-Guided PVI Ablation Reduces Atrial Tachyarrhythmia Recurrence
The use of adenosine to identify and eliminate dormant pulmonary vein conduction during radiofrequency ablation of paroxysmal atrial fibrillation (AF) significantly reduces recurrent atrial tachyarrhythmias, according to the results of a large, prospective, multicenter trial.


AF and PCI: Tailoring Antithrombotic Therapy to Optimize Outcomes
The goal of this activity is to provide an update on the clinical challenges of treating patients with atrial fibrillation who now need a percutaneous coronary intervention with regard to combining oral anticoagulants and antiplatelet therapy.


Cardiac Device Infections: Pathologies and Management Implications
Video – By Cleveland Clinic Heart Rhythm Society 2014 Symposium Featuring Sohail Rizwan


Case Presentation: Walking Through a Case of Epicardial VT Ablation
Case Presentation: Walking Through a Case of Epicardial VT Ablation by Dr. Kalyanam Shivkumar, UCLA Health System, Los Angeles, CA. Presented at the Cleveland Clinic Heart Rhythm Society 2014 Symposium.


Catheter Ablation for Ventricular Tachycardia
What is the long-term safety and effectiveness of radiofrequency catheter ablation (RFCA) in patients with coronary artery disease and sustained monomorphic ventricular tachycardia (SMVT)? – See more at: http://www.acc.org/Latest-in-Cardiology/Journal-Scans/2016/02/09/15/36/Long-Term-Success-of-Irrigated-Radiofrequency-Catheter-Ablation?


Challenging Cases in Atrial Fibrillation Management: Issues of Anticoagulation
Challenging Cases in Atrial Fibrillation Management: Issues of Anticoagulation by Dr. Eric Prystowsky, FACC Director of Cardiovascular, St Vincent Hospital, Indianapolis, IN.


CIED infection: Incidence, Predictors, Strategies for Prevention
Featuring Bruce Wilkoff


Comparative Chronic Valve and Venous Effects of Lumenless versus Stylet-Delivered Pacing Leads in Patients with and Without Congenital Heart
A study of 134 pediatric patients with and without congenital heart defects showed that a lumenless 4.1 Fr diameter pacing lead (Medtronic Model 3830) was associated with less adverse impact on atrioventricular valve integrity and venous obstruction compared to 5-7 Fr diameter pacing leads.


Confluent Extended Posterior Left Atrial Wall Ablation: Thinking Inside the Box
Here, we report intermediate follow-up details after using a technique of confluent posterior left atrial wall epicardial ablation designed to eliminate both existing and future atrial fibrillation (AF) substrates. The method is part of the Convergent hybrid procedure for AF ablation.


Cutting the cord: Leadless electrophysiology devices in practice
By Dr. Gaurav Upadhyay, University of Chicago, Chicago, IL. Presented at Innovations in Cardiovascular Therapeutics 2016.


Drivers in Relation to Duration of Persistent Atrial Fibrillation
What are the mechanisms and preferential sites of driver activity in patients with persistent atrial fibrillation (AF)?


ECG of the Month
List of monthly ECG quizzes.


How Innovations and Cybersecurity Impact Physicians and the Patients We Treat
Evaluate the importance of maintaining and enhancing medical device integrity in the dynamic and ever-evolving cybersecurity environment, while considering the potential patient health, safety and confidentiality impacts of cybersecurity in the context of medical technologies in healthcare. Review the balance for protecting patient safety and promoting the development of innovative technologies and improved technology performance. Review how to ensure the evaluation of cybersecurity is integrated with a holistic assessment of potential impacts on patient health, safety, and security of patient data, and health information, so patient and physician needs are balanced, and clinical perspectives considered with cybersecurity throughout the product lifecycle. Gain an understanding of the cybersecurity policies and procedures and communication processes that govern implantable devices throughout the product lifecycle. Gain an understanding of evolving communication standards and tools of the future that will enhance the cybersecurity of implanted medical devices.


Improve the prevention of sudden cardiac arrest in emerging countries: the Improve SCA clinical study design.
Primary prevention patients with syncope/pre-syncope, non-sustained VT, frequent PVCs, or LVEF < 25% risk factors (categorized as 1.5 Prevention) have been shown to be at similar risk of VT/VF as secondary prevention patients. The Improve SCA study will enroll 4800 ICD-eligible patients from Asia, Latin America, Eastern Europe, the Middle East, and Africa in order to confirm this risk, providing additional geographical-relevant evidence to inform shared decision making.


Improving Persistent AF Ablation Outcomes through a Multidisciplinary Approach
Review large unmet clinical need and challenges of treating persistent AF with current ablation approaches. Evaluate the safety and efficacy of dual epicardial and endocardial ablation for treating persistent or longstanding persistent AF. Assess outcomes data and clinical experiences for comprehensive posterior left atrial ablation in persistent AF patients.


Individual patient data network meta-analysis of mortality effects of implantable cardiac devices.
An individual patient-level meta-analysis of 13 randomized trials (n = 12,638) was performed to estimate the comparative mortality effects of ICDs, CRT-Ps, and CRT-Ds. These data can be used to estimate an individual patient’s expected and inform shared benefit decision making.


Journal CME/HeartRhythm Journal: March 2017 Vol. 14, Issue 3: Delayed efficacy of radiofrequency catheter ablation on ventricular arrhythmias originating from the left ventricular anterobasal wall
Ventricular arrhythmias (VAs) originating from the left ventricular anterobasal wall (LV-ABW) may represent a therapeutic challenge. The purpose of this study was to investigate the delayed efficacy of radiofrequency catheter (RFCA) ablation without an epicardial approach on VAs originating from the LV-ABW.


Late-Breaking Clinical Trial: “The POWDER-AF Trial”
Several Late-Breaking Clinical Trials were presented at Heart Rhythm 2017. Click on the link below to watch Mattias Duytschaever, MD, PhD review the “Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment In Subjects With Recurrent Atrial Fibrillation: Results From The POWDER-AF Multicentre Randomized Trial”


Magnet Function with Medtronic Cardiac Devices” on Medtronic Academy.
This course and reference tool are designed for physicians, nurses, radiologists, and all other medical personnel managing patients with Medtronic pacemakers and ICDs. It describes: how a magnet affects Medtronic pacemaker and ICD devices, clinical scenarios where a magnet can be used, how to prepare and monitor a patient once the clinician determines a magnet should be used. Must register first through Medtronic.


More Double Trouble: AF and Hypertension CME
Characterize the risk presented by patients with atrial fibrillation (AF) and hypertension Review the clinical trial experience with non-vitamin K antagonist oral anticoagulants (NOACs) vs warfarin in patients with hypertension


Natalia Trayanova, PhD “Reentrant Drivers Anchoring to Structural Heterogeneities: A Major Pathophysiological Mechanism of Human Persistent AF”
The mechanisms underlying persistent atrial fibrillation (AF) in patients with atrial fibrosis are poorly understood. Evidence from recent clinical and experimental studies suggests that persistent AF might be maintained by reentrant drivers (i.e., rotors), but the mechanisms linking reentrant driver formation and persistent AF perpetuation remain unknown.


On the Quest for the Best Freeze: Predictors of Late Pulmonary Vein Reconnections After Second-Generation Cryoballoon Ablation
The second-generation cryoballoon is effective in achieving acute pulmonary vein isolation (PVI) and favorable clinical outcome. To date, no data are available on factors affecting late PV reconnection after second-generation cryoballoon ablation.


Optimizing CRT through Device Programming
The plan reviews CRT device follow-up steps, discusses clinical evidence on the impact of RV pacing, and provides an overview of device algorithms that help ensure delivery of cardiac resynchronization therapy.


Patient Selection in Catheter Ablation for Atrial Fibrillation
Dr. Larry Chinitz, NYU Langone Medical Center, New York, NY. AF Ablation Video.


Periprocedural Management of Anticoagulation
Dr. John Doherty, Thomas Jefferson University Hospital, Philadelphia, PA.


Real-World Safety of NOACs: What Do We Know Today?
The goal of this activity is to improve understanding of real-world evidence regarding NOAC safety and efficacy.


Stroke Prevention in Atrial Fibrillation: Advancements in Oral Anticoagulation Therapy and LAA Closure
The Program Director, Dr. Vivek Reddy, and world-renowned faculty explore advancements in Left Atrial Appendage Closure (LAAC) and oral anticoagulation therapy for managing AF related stroke. Session highlights include Case Broadcasts from Mount Sinai Hospital, Device Reviews and Technical Considerations, AF-Related Stroke and Anticoagulation, LAAC Clinical Outcomes, Essentials for Advancing the Clinical Science, and Practical Aspects of LAAC.